Global Cord Blood Faces Remuneration Approval Hurdles
Company Announcements

Global Cord Blood Faces Remuneration Approval Hurdles

Global Cord Blood (CORBF) has released an update.

Global Cord Blood Corporation, in provisional liquidation, has faced setbacks with two inquorate extraordinary general meetings, leading to a court summons for the approval of the Joint Provisional Liquidators’ remuneration. Shareholders have raised questions regarding the remuneration terms, with a hearing set for July 30, 2024, to seek court sanction for the JPLs’ fees totaling over $10 million incurred during the previous year. Shareholders are encouraged to submit further comments or appear at the hearing to express their support or opposition.

For further insights into CORBF stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskGlobal Cord Blood Reports Ninth Liquidation Update
TipRanks Auto-Generated NewsdeskGlobal Cord Blood Faces EGM Quorum Issues
TipRanks Auto-Generated NewsdeskGlobal Cord Blood Seeks Court Remuneration Approval
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App